Malik Fady Ibraham
SEC CIK 1551778 · EDGAR
BoughtSold
Most active insiders at CYTK, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Blum Robert I | Pres, CEO, Dir | — | $17.08M |
| 2 | Callos Andrew | EVP, Chief Commercial Off | — | $16.02M |
| 3 | Lee Sung | EVP, CFO | — | $5.70M |
| 4 | Malik Fady Ibraham | EVP Research, Development | — | $4.65M |
| 5 | Kaye Edward M. MD | Dir | — | $3.21M |
| 6 | HENDERSON JOHN T | Dir | — | $2.08M |
| 7 | WIERENGA WENDELL | Dir | — | $1.88M |
| 8 | PARSHALL B LYNNE | Dir | — | $1.36M |
| 9 | Landry Robert E | Dir | — | $146.8K |
| 10 | Harrington Robert Arthur | Dir | — | $143.6K |
Transactions 174
Purchase Sale Sale after option exercise All abbreviations
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-09-22 18:14 | 2026-09-22 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.80 | +3,500 | 157.4K | +2% | +$27.3K |
| DT | 2026-09-22 18:14 | 2026-09-22 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $68.29 | -3,500 | 153.9K | -2% | -$239.0K |
| DT | 2026-09-08 16:38 | 2026-09-08 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.80 | +3,500 | 157.4K | +2% | +$27.3K |
| DT | 2026-09-08 16:38 | 2026-09-08 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $75.46 | -3,500 | 153.9K | -2% | -$264.1K |
| DT | 2026-08-18 16:38 | 2026-08-18 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.80 | +3,500 | 157.4K | +2% | +$27.3K |
| DT | 2026-08-18 16:38 | 2026-08-18 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $75.82 | -3,500 | 153.9K | -2% | -$265.4K |
| DT | 2026-07-23 16:09 | 2026-07-21 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.80 | +3,500 | 157.4K | +2% | +$27.3K |
| DT | 2026-07-23 16:09 | 2026-07-21 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $80.59 | -3,500 | 153.9K | -2% | -$282.1K |
| DT | 2026-07-07 17:06 | 2026-07-07 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.80 | +3,500 | 157.4K | +2% | +$27.3K |
| DT | 2026-07-07 17:06 | 2026-07-07 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $86.62 | -3,500 | 153.9K | -2% | -$303.2K |
| D | 2026-07-06 19:59 | 2026-06-18 | RCKT | ROCKET PHARMACEUTICALS, INC. | Malik Fady Ibraham | Dir | A - Grant | $0.00 | +22.9K | 52.9K | +76% | $0 |
| DT | 2026-06-23 17:41 | 2026-06-23 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.80 | +3,500 | 157.4K | +2% | +$27.3K |
| DT | 2026-06-23 17:41 | 2026-06-23 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $79.51 | -3,500 | 153.9K | -2% | -$278.3K |
| DT | 2026-06-09 17:40 | 2026-06-09 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.80 | +3,500 | 157.4K | +2% | +$27.3K |
| DT | 2026-06-09 17:40 | 2026-06-09 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $67.98 | -3,500 | 153.9K | -2% | -$237.9K |
| DT | 2026-05-20 16:00 | 2026-05-19 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.80 | +3,500 | 157.4K | +2% | +$27.3K |
| DT | 2026-05-20 16:00 | 2026-05-19 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $75.69 | -3,500 | 153.9K | -2% | -$264.9K |
| DT | 2026-05-05 17:35 | 2026-05-05 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.80 | +3,500 | 157.4K | +2% | +$27.3K |
| DT | 2026-05-05 17:35 | 2026-05-05 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $77.37 | -3,500 | 153.9K | -2% | -$270.8K |
| DT | 2026-04-21 16:22 | 2026-04-21 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.80 | +3,500 | 157.4K | +2% | +$27.3K |
| DT | 2026-04-21 16:22 | 2026-04-21 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $65.69 | -3,500 | 153.9K | -2% | -$229.9K |
| DMT | 2026-04-08 16:18 | 2026-04-07 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $8.42 | +4,500 | 154.9K | +3% | +$37.9K |
| DMT | 2026-04-08 16:18 | 2026-04-07 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $65.11 | -4,500 | 153.9K | -3% | -$293.0K |
| M | 2026-03-18 | 2026-03-17 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale | $62.15 | -12.0K | 158.3K | -7% | -$747.9K |
| D | 2026-03-17 | 2026-03-15 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | A - Grant | $0.00 | +27.3K | 165.9K | +20% | $0 |
| 2026-03-10 | 2026-03-09 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale | $60.72 | -2,907 | 138.6K | -2% | -$176.5K | |
| 2025-12-29 | 2025-12-22 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | F - Tax | $62.72 | -1,016 | 141.5K | -0.7% | -$63.7K | |
| M | 2025-12-29 | 2025-12-22 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | A - Grant | $0.00 | +4,000 | 142.6K | +3% | $0 |
| D | 2025-12-16 | 2025-12-16 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $10.60 | +2,200 | 140.8K | +2% | +$23.3K |
| D | 2025-12-16 | 2025-12-16 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $61.24 | -2,200 | 138.6K | -2% | -$134.7K |
| 2025-12-05 | 2025-12-03 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | F - Tax | $65.02 | -2,058 | 138.6K | -1% | -$133.8K | |
| D | 2025-12-02 | 2025-12-02 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $10.60 | +2,200 | 142.8K | +2% | +$23.3K |
| D | 2025-12-02 | 2025-12-02 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $63.89 | -2,200 | 140.6K | -2% | -$140.6K |
| D | 2025-11-18 | 2025-11-18 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $10.60 | +2,200 | 142.8K | +2% | +$23.3K |
| D | 2025-11-18 | 2025-11-18 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $66.45 | -2,200 | 140.6K | -2% | -$146.2K |
| D | 2025-11-04 | 2025-11-04 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $59.55 | -2,295 | 140.6K | -2% | -$136.7K |
| D | 2025-11-04 | 2025-11-04 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $10.60 | +2,295 | 142.9K | +2% | +$24.3K |
| D | 2025-10-21 | 2025-10-21 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $10.60 | +2,105 | 142.7K | +1% | +$22.3K |
| D | 2025-10-21 | 2025-10-21 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $58.22 | -2,105 | 140.6K | -1% | -$122.6K |
| D | 2025-10-07 | 2025-10-07 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $60.56 | -2,000 | 140.6K | -1% | -$121.1K |
| D | 2025-10-07 | 2025-10-07 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $10.60 | +2,000 | 142.6K | +1% | +$21.2K |
| D | 2025-09-23 | 2025-09-23 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $49.28 | -2,000 | 140.6K | -1% | -$98.6K |
| D | 2025-09-23 | 2025-09-23 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $10.60 | +2,000 | 142.6K | +1% | +$21.2K |
| D | 2025-09-10 | 2025-09-09 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $51.29 | -2,000 | 140.6K | -1% | -$102.6K |
| D | 2025-09-10 | 2025-09-09 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $10.60 | +2,000 | 142.6K | +1% | +$21.2K |
| D | 2025-08-19 | 2025-08-19 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $10.60 | +2,000 | 142.6K | +1% | +$21.2K |
| D | 2025-08-19 | 2025-08-19 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $38.31 | -2,000 | 140.6K | -1% | -$76.6K |
| D | 2025-08-05 | 2025-08-05 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $10.60 | +2,000 | 142.6K | +1% | +$21.2K |
| D | 2025-08-05 | 2025-08-05 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $36.34 | -2,000 | 140.6K | -1% | -$72.7K |
| D | 2025-07-23 | 2025-07-22 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $37.47 | -2,000 | 140.6K | -1% | -$74.9K |
| D | 2025-07-23 | 2025-07-22 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $10.60 | +2,000 | 142.6K | +1% | +$21.2K |
| 2025-07-18 | 2025-06-18 | RCKT | ROCKET PHARMACEUTICALS, INC. | Malik Fady Ibraham | Dir | A - Grant | $0.00 | +30.0K | 30.0K | New | $0 | |
| D | 2025-07-08 | 2025-07-08 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $33.76 | -2,000 | 140.6K | -1% | -$67.5K |
| D | 2025-07-08 | 2025-07-08 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $10.60 | +2,000 | 142.6K | +1% | +$21.2K |
| D | 2025-06-17 | 2025-06-17 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $10.60 | +2,000 | 142.6K | +1% | +$21.2K |
| D | 2025-06-17 | 2025-06-17 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $32.91 | -2,000 | 140.6K | -1% | -$65.8K |
| D | 2025-06-03 | 2025-06-03 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $10.60 | +2,000 | 142.6K | +1% | +$21.2K |
| D | 2025-06-03 | 2025-06-03 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $31.88 | -2,000 | 140.6K | -1% | -$63.8K |
| D | 2025-05-20 | 2025-05-20 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $10.60 | +2,000 | 142.3K | +1% | +$21.2K |
| D | 2025-05-20 | 2025-05-20 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $31.98 | -2,000 | 140.3K | -1% | -$64.0K |
| D | 2025-05-06 | 2025-05-06 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $35.01 | -2,000 | 140.3K | -1% | -$70.0K |
| D | 2025-05-06 | 2025-05-06 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $10.60 | +2,000 | 142.3K | +1% | +$21.2K |
| D | 2025-04-22 | 2025-04-22 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $10.60 | +2,000 | 142.3K | +1% | +$21.2K |
| D | 2025-04-22 | 2025-04-22 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $38.11 | -2,000 | 140.3K | -1% | -$76.2K |
| D | 2025-04-08 | 2025-04-08 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $10.60 | +2,000 | 142.3K | +1% | +$21.2K |
| D | 2025-04-08 | 2025-04-08 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $36.18 | -2,000 | 140.3K | -1% | -$72.4K |
| 2025-03-19 | 2025-03-19 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | G - Gift | $0.00 | -200 | 140.3K | -0.1% | $0 | |
| D | 2025-03-18 | 2025-03-14 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | A - Grant | $0.00 | +39.5K | 144.8K | +37% | $0 |
| D | 2025-03-18 | 2025-03-18 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $43.58 | -2,000 | 140.5K | -1% | -$87.2K |
| D | 2025-03-18 | 2025-03-18 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $10.60 | +2,000 | 142.5K | +1% | +$21.2K |
| 2025-03-17 | 2025-03-17 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale | $44.38 | -4,389 | 101.0K | -4% | -$194.8K | |
| 2025-03-07 | 2025-03-06 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale | $43.27 | -8,228 | 105.4K | -7% | -$356.0K | |
| 2025-03-05 | 2025-03-03 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale | $42.88 | -2,449 | 113.6K | -2% | -$105.0K | |
| D | 2025-03-04 | 2025-03-04 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $42.50 | -2,000 | 116.1K | -2% | -$85.0K |
| D | 2025-03-04 | 2025-03-04 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $10.60 | +2,000 | 118.1K | +2% | +$21.2K |
| D | 2025-02-18 | 2025-02-18 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $10.60 | +2,000 | 118.1K | +2% | +$21.2K |
| D | 2025-02-18 | 2025-02-18 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $45.98 | -2,000 | 116.1K | -2% | -$92.0K |
| D | 2025-02-04 | 2025-02-04 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $10.60 | +2,000 | 118.1K | +2% | +$21.2K |
| D | 2025-02-04 | 2025-02-04 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $48.06 | -2,000 | 116.1K | -2% | -$96.1K |
| D | 2025-01-21 | 2025-01-21 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $10.60 | +2,000 | 118.1K | +2% | +$21.2K |
| D | 2025-01-21 | 2025-01-21 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $45.92 | -2,000 | 116.1K | -2% | -$91.8K |
| D | 2025-01-10 | 2025-01-07 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $10.60 | +2,000 | 118.1K | +2% | +$21.2K |
| D | 2025-01-10 | 2025-01-07 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $49.32 | -2,000 | 116.1K | -2% | -$98.6K |
| D | 2024-12-10 | 2024-12-10 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.96 | +5,300 | 123.4K | +4% | +$42.2K |
| DM | 2024-12-10 | 2024-12-10 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $50.64 | -7,300 | 118.1K | -6% | -$369.6K |
| M | 2024-12-05 | 2024-12-03 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | A - Grant | $0.00 | +8,000 | 118.1K | +7% | $0 |
| 2024-12-05 | 2024-12-03 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | F - Tax | $51.51 | -2,028 | 114.1K | -2% | -$104.5K | |
| D | 2024-11-26 | 2024-11-26 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.96 | +5,300 | 119.2K | +5% | +$42.2K |
| DM | 2024-11-26 | 2024-11-26 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $50.16 | -7,300 | 111.9K | -6% | -$366.2K |
| D | 2024-11-13 | 2024-11-12 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.96 | +5,300 | 120.2K | +5% | +$42.2K |
| DM | 2024-11-13 | 2024-11-12 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $58.48 | -6,342 | 114.9K | -5% | -$370.9K |
| D | 2024-10-31 | 2024-10-30 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.96 | +5,300 | 122.2K | +5% | +$42.2K |
| DM | 2024-10-31 | 2024-10-30 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $51.91 | -7,300 | 116.9K | -6% | -$378.9K |
| D | 2024-10-16 | 2024-10-15 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.96 | +5,300 | 124.2K | +4% | +$42.2K |
| DM | 2024-10-16 | 2024-10-15 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $54.19 | -7,300 | 118.9K | -6% | -$395.6K |
| DM | 2024-10-01 | 2024-10-01 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $52.10 | -7,300 | 118.9K | -6% | -$380.3K |
| D | 2024-10-01 | 2024-10-01 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.96 | +5,300 | 124.2K | +4% | +$42.2K |
| DM | 2024-09-17 | 2024-09-17 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $56.77 | -7,300 | 122.9K | -6% | -$414.4K |
| D | 2024-09-17 | 2024-09-17 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.96 | +5,300 | 128.2K | +4% | +$42.2K |
| DM | 2024-09-03 | 2024-09-03 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $57.01 | -7,384 | 122.9K | -6% | -$421.0K |